Quarterly Activities/Appendix 4C Cash Flow Report
Filed with ASX · · 10 pages · English
• Strong progress across the emu™ Pivotal (Validation) Trial, with seven world-class stroke hospitals activated and recruiting, following the addition of a second Mt Sinai (New York) network hospital. • Activation of a second Memorial Hermann (Houston) network hospital in final stages, supporting recruitment momentum and access to diverse stroke populations. • Grant-funded Regional Benefits Study
EMvision Medical Devices Ltd. on 6ix
Earlier from EMvision Medical Devices
- Strong emu Clinical Trial & Program Progress
- First Responder Aeromedical Study Commences
- Oversubscribed SPP Raises $2.0M
- Oversubscribed SPP To Close Early
- $3m CRC-P Grant Executed & First Payment Received
Later from EMvision Medical Devices
- Half Yearly Report and Accounts
- EMVision Medical Devices to Present at Australia Investor Day February 26th
- S&P DJI Announces March 2026 Quarterly Rebalance
- Update - S&P DJI March 2026 Rebalance of the All Ordinaries
- $3.8m R&D Rebate Received & Overseas Finding Approved
Follow EMvision Medical Devices into a list and get an email when it puts out news.
Follow EMvision Medical Devices